C41 LONG ACTING BRONCHODILATOR THERAPY IN COPD II: Evaluation Of The Safety Of Long-Term Use Of Perforomist® (formoterol Fumarate) Inhalation Solution In Patients With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD)

Subjects (N=1071; mean age, 62.6 years; 48.5% male; 89.7% white) with moderate to severe COPD (mean postbronchodilator forced expiratory volume in 1 second [FEV1 ], 44.4% of predicted value; >1 exacerbation in past 12 months) and on stable COPD therapy received nebulized Perforomist (20 ^g/2 mL t...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of respiratory and critical care medicine 2017-01, Vol.195
Hauptverfasser:	Hanania, N, Sethi, S, Koltun, A, Ward, J, Spanton, J, Ng, D
Format:	Artikel
Sprache:	eng
Schlagworte:	Bronchodilators Chronic obstructive pulmonary disease Inhalers
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!